2ndAnnual Artificial Intelligence in Drug Development CongressBy CIOApplications Europe
The 2nd Annual Artificial Intelligence in Drug Development Congress is part of PharmaTec Event Series that features 3 outstanding programmes: our long-running Pharma IT Congress and fast-emerging Artificial Intelligence in Drug Development and Digital Health & Digital Technologies Congresses.
This event will host over 300 attendees who will be representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions.
There will be over 30 presentations and case studies focussed on the innovative application of artificial intelligence in drug discovery and cheminformatics, alongside machine learning in clinical trials and big data.
Our world-renowned experts will be presenting across3 interactive streams, including;
• AI in Drug Discovery and Discovery Chemistry
• Machine Learning and Personalising Patient Treatments
•AI in Big Data and Clinical Research Development
This event will once again be co-located with the16th Annual Pharmaceutical IT Congress. This year the congress will also be co-located with the highly anticipated inauguralDigital Health & Digital Technologies Congress.
Free Pre-Congress Live Webinars
Artificial Intelligence in Drug Development: The Opportunity
Slava Akmaev, Chief Analytics Officer, BERG Health
AI-Driven Pre-Clinical Drug Design, Discovery and Development
George Okafo, Senior Director Insilico Drug Discovery Unit, GlaxoSmithKline
Alternatively visit our websitehttps://bit.ly/2EozKvC